R-spondin-4



R-spondin-4

L1LL1N2NN2R3RR3R4RR4K5KK5K6KK6Q7QQ7V8VV8G9GG9T10TT10G11GG11L12LL12G13GG13G14GG14N15NN15C16CC16T17TT17G18GG18C19CC19I20II20I21II21C22CC22S23SS23E24EE24E25EE25N26NN26G27GG27C28CC28S29SS29T30TT30C31CC31Q32QQ32Q33QQ33R34RR34L35LL35F36FF36L37LL37F38FF38I39II39R40RR40R41RR41E42EE42G43GG43I44II44R45RR45Q46QQ46Y47YY47... and 168 more residue(s)...... and 168 more residue(s)

SMILES None
InChIKey None
Sequence LNRRKKQVGTGLGGNCTGCIICSEENGCSTCQQRLFLFIRREGIRQYGKCLHDCPPGYFGIRGQEVNRCKKCGATCESCFSQDFCIRCKRQFYLYKGKCLPTCPPGTLAHQNTRECQGECELGPWGGWSPCTHNGKTCGSAWGLESRVREAGRAGHEEAATCQVLSESRKCPIQRPCPGERSPGQKKGRKDRRPRKDRKLDRRLDVRPRQPGLQP

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

R-spondin-4

L1LL1N2NN2R3RR3R4RR4K5KK5K6KK6Q7QQ7V8VV8G9GG9T10TT10G11GG11L12LL12G13GG13G14GG14N15NN15C16CC16T17TT17G18GG18C19CC19I20II20I21II21C22CC22S23SS23E24EE24E25EE25N26NN26G27GG27C28CC28S29SS29T30TT30C31CC31Q32QQ32Q33QQ33R34RR34L35LL35F36FF36L37LL37F38FF38I39II39R40RR40R41RR41E42EE42G43GG43I44II44R45RR45Q46QQ46Y47YY47... and 168 more residue(s)...... and 168 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.